RRTNews reports today that Cephalon says that their pain medication Fentora gives faster pain relief in cancer patients and people with chronic pain conditions.

“Cephalon Inc. (CEPH) reported positive results from two Phase III clinical trials of its drug Fentora, in the treatment of opioid-tolerant patients with breakthrough pain associated with chronic pain conditions as well as opioid-tolerant patients with cancer.”

“Fentora, approved by the FDA in September 2006, is the first pain reliever in seven years to be approved for the management of breakthrough pain in cancer patients who are already taking opioids for underlying, persistent cancer pain. In the earlier clinical trials submitted as part of the Fentora New Drug Application, the company evaluated pain relief at 15 minutes. It usually takes 30-45 minutes for other pain medications to take effect.”

Full story from RRTNews.